FDA Advisory Warns Of Fatal Cardiac, Respiratory Risks Associated With Methadone
This article was originally published in The Pink Sheet Daily
Executive Summary
Public health advisory notes that use of the Boehringer Ingelheim drug may cause death or life-threatening injury during initiation or conversion of pain patients to methadone from other opioid agonists.